Home › Funds › Kynam Capital Management, LP › BNR
Kynam Capital Management, LP position in BNR
BURNING ROCK BIOTECH LTD · Health Care
Kynam Capital Management, LP reported holding 1,238,563 shares of BNR (BURNING ROCK BIOTECH LTD) in its Q2 2026 13F filing — a position valued at US$10.5M, representing 0.58% of its reported portfolio and ranking #23 among its reported holdings. Kynam Capital Management, LP has disclosed BNR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Kynam Capital Management, LP's BNR position evolved
Kynam Capital Management, LP first disclosed a stake in BNR in Q3 2023 at 8,500,000 shares (US$8.2M). The position peaked in Q4 2025 at 994,883 shares, worth US$20.0M. Across 12 filings, Kynam Capital Management, LP increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 1,238,563 shares valued at US$10.5M — an increase of 11,008 shares quarter over quarter.. Notable position changes include a 90% trim in Q2 2024 (shares fell 49% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 8.50M | $8.24M | New |
| Q4 2023 | 8.69M | $8.09M | Add |
| Q1 2024 | 9.64M | $7.02M | Add |
| Q2 2024 | 974.67K | $6.28M | Reduce |
| Q3 2024 | 989.22K | $3.23M | Add |
| Q4 2024 | 994.88K | $6.72M | Add |
| Q1 2025 | 994.88K | $4.38M | Hold |
| Q2 2025 | 994.88K | $3.14M | Hold |
| Q3 2025 | 994.88K | $8.61M | Hold |
| Q4 2025 | 994.88K | $20.05M | Hold |
| Q1 2026 | 1.23M | $19.79M | Add |
| Q2 2026 | 1.24M | $10.52M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BNR and 13F data
BNR (BURNING ROCK BIOTECH LTD) is a Health Care company. 18 other funds we track also report a position in BNR — the largest reported positions include CRCM LP (US$1.8M), HSG Holding Ltd (US$178K), SHEN NEIL NANPENG (US$36K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BNR
- CRCM LP 212.00K sh · $1.77M · Q2 2026
- HSG Holding Ltd 21.21K sh · $177.54K · Q2 2026
- SHEN NEIL NANPENG 885 sh · $36.34K · Q4 2025
More on Kynam Capital Management, LP
FAQ
How long has Kynam Capital Management, LP held BNR?
Kynam Capital Management, LP has disclosed BNR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Kynam Capital Management, LP's current position in BNR?
As of Q2 2026, Kynam Capital Management, LP holds 1.24M shares of BNR (BURNING ROCK BIOTECH LTD), valued at $10.52M, representing 0.58% of its reported portfolio and ranking #23.
Has Kynam Capital Management, LP been buying or selling BNR?
In the latest 13F filing (Q2 2026), Kynam Capital Management, LP increased its position in BNR. The position peaked in Q4 2025 at 994.88K shares.
Which other funds hold BNR?
Other major institutional holders of BNR include CRCM LP, HSG Holding Ltd, SHEN NEIL NANPENG, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.